Meta to Invest Up to 65 Billion in AI and Data Center Expansion Signaling SectorWide Acceleration US Consumer Sentiment Remains Pessimistic Inflation Tariffs and Geopolitical Tensions Weigh on Outlook Fed Rate Hike Expectations Resurface as Inflation Surges Guzman y Gomez Exits US Market Citing Intense Competition and High Costs Twenty One Capital Stock Jumps on Major Bitcoin Pivot Momentum May Depend on Institutional Demand Airtel Defends Priority Postpaid Plan Before DoT Denies Net Neutrality Breach Myriad Genetics Q1 2026 Earnings EPS Miss Highlights Continued Operational Challenges eBay Q1 2026 Earnings EPS Beat Slightly Overshadowed by Subdued Market Reaction IDT Q1 2026 Earnings Mixed Quarter as Earnings Miss Estimates but Stock Edges Higher LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline Addentax Group Corp ATXG Q1 2025 Earnings Net Loss Deepens Amid Low Trading Volume SEE Q4 2025 Earnings EPS Surpasses Estimates by 43 Revenue Details Remain Undisclosed Crane Harbor Acquisition Corp CHAC Surges 848 as Speculation Surrounds Potential Merger Catalyst Wave Life Sciences WVE Gains 2 Holds Above Key Support Amid Biotech Sector Moves NPK International Inc NPKI Edges Lower Amid Modest Pullback Trailblazer Acquisition Corp BLZR Holds Steady at 1011 Amid Low Volatility Shattuck Labs STTK Holds Steady at 61 Testing Familiar Support Levels Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress VAC Q1 2026 Earnings Earnings Miss Estimates Despite Stable Share Price Trustmark Corporation TRMK Q1 2026 Earnings EPS Beat Offsets Flat Market Reaction QFIN Q4 2025 Earnings EPS Misses Estimates Shares Decline 574 TRIP Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Uncertainty LASR Q1 2026 Earnings EPS Blows Past Estimates with 126 Surprise Piper Sandler Raises Price Target on Charles Schwab to 105 Citing Revenue Upside from Net Interest Margin Improvement ACU Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges Rapport Therapeutics RAPP Holds Steady Near 3950 as Support and Resistance Levels Come into Focus